Risk for all vascular events across HDL-c quartiles, with or without lipid-lowering therapy
2
Risk for all vascular events across HDL- c quartiles, with or without lipid-lowering therapy HR 2 1 0,5 1 2 3 4 No lipid-lowering medication Lipid-lowering medication Van de Woestijne et al., JACC 2013
-
Upload
zelda-rutledge -
Category
Documents
-
view
23 -
download
2
description
Risk for all vascular events across HDL-c quartiles, with or without lipid-lowering therapy. No lipid-lowering medication. 2. Lipid-lowering medication. 1. HR. 0,5. 1. 2. 3. 4. Van de Woestijne et al ., JACC 2013. - PowerPoint PPT Presentation
Transcript of Risk for all vascular events across HDL-c quartiles, with or without lipid-lowering therapy
Risk for all vascular events across HDL-c quartiles, with or without lipid-lowering therapy
HR
2
1
0,5
1 2 3 4
No lipid-lowering medicationLipid-lowering medication
Van de Woestijne et al., JACC 2013
Risk for all vascular events across HDL-c quartiles, with/without intensive lipid-lowering therapy
1 2 3 4
HR
0,5
2
1
No intensive lipid-lowering therapyIntensive lipid-lowering therapy
Van de Woestijne et al., JACC 2013